Endocarditis (Staphylococcus epidermidis)
Overview
Plain-Language Overview
Endocarditis caused by Staphylococcus epidermidis is an infection of the inner lining of the heart, especially affecting the heart valves. This condition involves the cardiovascular system and can lead to serious problems by damaging the heart valves and disrupting normal blood flow. The infection is often linked to medical devices like artificial heart valves or catheters, where the bacteria form protective layers called biofilms. Symptoms may include fever, fatigue, and heart murmurs, reflecting the body's response to infection and valve damage. If untreated, it can cause severe complications such as heart failure or spread of infection to other organs.
Clinical Definition
Endocarditis (Staphylococcus epidermidis) is a form of infective endocarditis characterized by infection of the endocardial surface, predominantly involving prosthetic heart valves or indwelling cardiac devices. The core pathology involves bacterial colonization and biofilm formation by Staphylococcus epidermidis, a coagulase-negative staphylococcus known for its ability to adhere to foreign materials and evade host immune responses. This leads to the development of vegetations composed of bacteria, fibrin, and inflammatory cells on the valve surface. Clinically, it presents with fever, new or changing heart murmurs, and signs of systemic embolization or immune complex deposition. The condition is significant due to its association with prosthetic valve endocarditis, which carries a high risk of morbidity and mortality. Diagnosis and management are complicated by the organism’s resistance to multiple antibiotics and its biofilm-mediated persistence.
Inciting Event
Bacterial seeding of prosthetic material during or after cardiac surgery.
Transient bacteremia from skin flora during invasive procedures or catheter manipulation.
Colonization of indwelling devices by Staphylococcus epidermidis biofilm formation.
Breaks in skin integrity allowing entry of commensal S. epidermidis into bloodstream.
Latency Period
Weeks to months after prosthetic valve implantation before symptom onset is typical.
Subacute progression with slow development of symptoms over several weeks.
Delayed presentation compared to native valve endocarditis due to biofilm protection.
Diagnostic Delay
Indolent symptom onset leads to low clinical suspicion early in disease.
Negative or low-grade blood cultures due to biofilm-associated bacteria.
Misattribution of symptoms to other causes such as heart failure or noninfectious inflammation.
Difficulty detecting vegetations on echocardiography in prosthetic valves.
Clinical Presentation
Signs & Symptoms
Fever and chills as systemic inflammatory response
Fatigue and malaise from chronic infection
New or worsening heart murmur indicating valvular involvement
Signs of embolic phenomena such as stroke or limb ischemia
Symptoms of heart failure if valve dysfunction is severe
History of Present Illness
Low-grade fever and malaise persisting for weeks are common initial symptoms.
New or changing heart murmur may develop gradually.
Symptoms of heart failure such as dyspnea and fatigue can appear as valve dysfunction progresses.
Embolic phenomena causing focal neurological deficits or skin lesions may occur later.
Past Medical History
Prosthetic heart valve replacement or valve repair surgery.
Presence of intracardiac devices like pacemakers or defibrillators.
Recent hospitalization or invasive procedures involving vascular access.
Chronic immunosuppressive therapy or underlying immunodeficiency.
Family History
[]
Physical Exam Findings
New or changing heart murmur, often a regurgitant murmur due to valve destruction
Petechiae on skin or mucous membranes from microemboli
Splinter hemorrhages under fingernails indicating microvascular emboli
Janeway lesions, painless erythematous macules on palms and soles from septic emboli
Osler nodes, tender subcutaneous nodules on fingers or toes from immune complex deposition
Diagnostic Workup
Diagnostic Criteria
Diagnosis relies on the Modified Duke Criteria, which include positive blood cultures for Staphylococcus epidermidis and evidence of endocardial involvement on echocardiography. Key findings include persistent bacteremia with coagulase-negative staphylococci, especially in patients with prosthetic valves or cardiac devices, and visualization of vegetations or abscesses on transesophageal echocardiogram. Additional minor criteria include fever, vascular phenomena, and immunologic signs. Confirmatory diagnosis requires integration of clinical, microbiological, and imaging data to distinguish true infection from contamination.
Pathophysiology
Key Mechanisms
Biofilm formation on prosthetic material by Staphylococcus epidermidis protects bacteria from host immune response and antibiotics.
Adherence to prosthetic heart valves or indwelling devices initiates infection.
Chronic inflammation due to persistent bacterial colonization leads to vegetation formation.
Immune evasion through polysaccharide capsule and slow bacterial growth within biofilms.
Septic emboli can cause systemic complications from vegetation fragmentation.
| Involvement | Details |
|---|---|
| Organs | Heart is the primary organ affected, with infection of the endocardium and heart valves causing structural damage and clinical manifestations. |
Kidneys may be affected by immune complex deposition causing glomerulonephritis as a complication of endocarditis. | |
| Tissues | Endocardium is the inner lining of the heart where vegetations form during infective endocarditis. |
Valvular tissue is damaged and colonized by bacteria leading to vegetation formation and valve dysfunction. | |
| Cells | Neutrophils are the primary immune cells that phagocytose and kill Staphylococcus epidermidis during endocarditis. |
Macrophages contribute to granulomatous inflammation and clearance of bacterial debris in infected cardiac tissue. | |
Platelets aggregate on damaged endothelium and contribute to vegetation formation on heart valves. | |
| Chemical Mediators | Interleukin-1 (IL-1) promotes inflammation and fever during the immune response to infection. |
Tumor necrosis factor-alpha (TNF-α) mediates systemic inflammatory response and tissue damage in endocarditis. | |
C-reactive protein (CRP) is an acute phase reactant elevated in response to bacterial infection and inflammation. |
Treatments
Pharmacological Treatments
Vancomycin
- Mechanism:
Inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala terminus of cell wall precursors.
- Side effects:
Nephrotoxicity
Ototoxicity
Red man syndrome
- Clinical role:
First-line
Gentamicin
- Mechanism:
Binds to 30S ribosomal subunit causing misreading of mRNA and inhibiting protein synthesis.
- Side effects:
Nephrotoxicity
Ototoxicity
Neuromuscular blockade
- Clinical role:
Adjunctive
Rifampin
- Mechanism:
Inhibits bacterial DNA-dependent RNA polymerase, suppressing RNA synthesis.
- Side effects:
Hepatotoxicity
Orange discoloration of body fluids
Drug interactions
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Surgical valve replacement or debridement is indicated in cases of prosthetic valve dysfunction, persistent infection, or large vegetations causing embolic risk.
Removal of infected intravascular devices such as central venous catheters is essential to eradicate infection.
Supportive care includes management of heart failure and embolic complications.
Prevention
Pharmacological Prevention
Prophylactic antibiotics (e.g., amoxicillin) before dental or invasive procedures in high-risk patients
Aseptic technique and antibiotic lock therapy for indwelling catheters to prevent biofilm formation
Early targeted antibiotic therapy for bacteremia to prevent endocarditis
Non-pharmacological Prevention
Strict sterile technique during insertion and maintenance of prosthetic devices
Regular dental hygiene and care to reduce bacteremia risk
Removal or replacement of infected prosthetic material when feasible
Screening and monitoring of high-risk patients with prosthetic valves or devices
Outcome & Complications
Complications
Valve destruction leading to severe regurgitation and heart failure
Septic emboli causing stroke, infarcts, or abscesses
Perivalvular abscess formation with conduction abnormalities
Persistent bacteremia and sepsis
Glomerulonephritis from immune complex deposition
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Endocarditis (Staphylococcus epidermidis) versus Staphylococcus aureus Endocarditis
Endocarditis (Staphylococcus epidermidis) | Staphylococcus aureus Endocarditis |
|---|---|
Gram-positive cocci in clusters, coagulase-negative | Gram-positive cocci in clusters, coagulase-positive |
Usually subacute or chronic with lower virulence | Typically acute, rapidly progressive with high virulence |
Commonly linked to prosthetic valves or indwelling catheters | Often associated with intravenous drug use or healthcare exposure |
Endocarditis (Staphylococcus epidermidis) versus Viridans Group Streptococci Endocarditis
Endocarditis (Staphylococcus epidermidis) | Viridans Group Streptococci Endocarditis |
|---|---|
Gram-positive cocci in clusters, coagulase-negative | Gram-positive cocci in chains, alpha-hemolytic |
Subacute but often associated with prosthetic material | Subacute course with insidious onset |
Frequently related to prosthetic valve or device implantation | Often follows dental procedures or poor dentition |
Endocarditis (Staphylococcus epidermidis) versus Candida Endocarditis
Endocarditis (Staphylococcus epidermidis) | Candida Endocarditis |
|---|---|
Coagulase-negative staphylococci, no yeast forms | Yeast forms seen on culture or histology |
Often in patients with prosthetic valves or indwelling catheters | Common in immunocompromised patients or prolonged antibiotic use |
Responds to targeted antibiotic therapy against coagulase-negative staphylococci | Requires antifungal therapy and often surgical intervention |
Endocarditis (Staphylococcus epidermidis) versus Enterococcal Endocarditis
Endocarditis (Staphylococcus epidermidis) | Enterococcal Endocarditis |
|---|---|
Gram-positive cocci in clusters, coagulase-negative | Gram-positive cocci in chains, often resistant to many antibiotics |
Associated with prosthetic devices or intravascular catheters | Associated with genitourinary or gastrointestinal procedures |
Usually treated with vancomycin or oxacillin depending on susceptibility | Requires combination antibiotic therapy due to resistance |